Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42574 (
caspase-3
)
45,978
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Pim-1 oncoprotein is a serine/threonine kinase that can closely cooperate with
c-Myc
in lymphomagenesis, as does Bcl-2. Although the molecular mechanism of this cooperative transformation remains unknown, it is speculated that, similar to Bcl-2, Pim-1 contributes to transformation by inhibiting apoptosis. In this study, therefore, we examined the effect of Pim-1 expression on
c-Myc
-mediated apoptosis of Rat-1 fibroblasts triggered by serum deprivation. Our results showed that, rather than inhibiting apoptosis, Pim-1 expression stimulated
c-Myc
-mediated apoptosis in Rat-1 fibroblasts. Pim-1 stimulated
c-Myc
-mediated apoptosis through an enhancement of the
c-Myc
-mediated activation of
caspase-3
(CPP32)-like proteases, since the suppression of this activity by a specific caspase inhibitor abolished the apoptosis stimulation by Pim-1. A kinase-defective Pim-1 mutant failed to stimulate
c-Myc
-mediated apoptosis, and Pim-1 expression alone in the absence of
c-Myc
overexpression did not induce apoptosis of serum-deprived Rat-1 cells, indicating that the kinase activity of Pim-1 and the activated
c-Myc
signaling pathway were required for apoptosis stimulation by Pim-1. Together, these results suggest that Pim-1 oncoprotein stimulates as a serine/threonine kinase the death signaling elicited by
c-Myc
at a step upstream of
caspase-3
-like protease activation in Rat-1 fibroblasts. Our results also suggest that Pim-1 kinase might function cooperatively with
c-Myc
through the phosphorylation of a factor(s) which regulates the common signaling pathway involved in
c-Myc
-mediated apoptosis and transformation.
...
PMID:Pim-1 kinase stimulates c-Myc-mediated death signaling upstream of caspase-3 (CPP32)-like protease activation. 933 23
Upon activation, cell surface death receptors, Fas/APO-1/CD95 and tumor necrosis factor receptor-1 (TNFR-1), are attached to cytosolic adaptor proteins, which in turn recruit caspase-8 (MACH/FLICE/Mch5) to activate the interleukin-1 beta-converting enzyme (ICE)/CED-3 family protease (caspase) cascade. However, it remains unknown whether these apoptotic proteases are generally involved in apoptosis triggered by other stimuli such as Myc and p53. In this study, we provide lines of evidence that a death protease cascade consisting of caspases and serine proteases plays an essential role in Myc-mediated apoptosis. When Rat-1 fibroblasts stably expressing either s-Myc or
c-Myc
were induced to undergo apoptosis by serum deprivation, a
caspase-3
(CPP32)-like protease activity that cleaves a specific peptide substrate, Ac-DEVD-MCA, appeared in the cell lysates. Induction of s-Myc- and
c-Myc
-mediated apoptotic cell death was effectively prevented by caspase inhibitors such as Z-Asp-CH2-DCB and Ac-DEVD-CHO. Furthermore, exposing the cells to a serine protease inhibitor, 4-(2-aminoethyl)benzenesulfonyl fluoride (AEBSF), also significantly inhibited s-Myc- and
c-Myc
-mediated apoptosis and the appearance of the
caspase-3
-like protease activity in vivo. However, AEBSF did not directly inhibit
caspase-3
-like protease activity in the apoptotic cell lysates in vitro. Together, these results indicate that
caspase-3
-like proteases play a critical role in both s-Myc- and
c-Myc
-mediated apoptosis and that
caspase-3
-like proteases function downstream of the AEBSF-sensitive step in the signaling pathway of Myc-mediated apoptosis.
...
PMID:A functional role for death proteases in s-Myc- and c-Myc-mediated apoptosis. 934 38
c-Myc
is a transcriptional activator implicated in the control of cell proliferation, differentiation and transformation, but is also involved in the regulation of programmed cell death, apoptosis. Despite intensive research, the molecular mechanisms by which
c-Myc
triggers and executes cell death remain still elusive. Here, we made use of Rat 1A MycER cells expressing a conditionally active
c-Myc
protein and tested first the hypothesis that ornithine decarboxylase (ODC), which is a transcriptional target of
c-Myc
, were a mediator of
c-Myc
-induced apoptosis. However, our results show that the activity of ODC is not required for the
c-Myc
-mediated apoptosis to occur in these cells. We also found that the expression of p53, p21waf1/cip1, Bcl-2, Bax, Bcl-xL, Bad and cyclins D1, E, A and B did not show any significant changes following
c-Myc
induction. But, our studies revealed that the
c-Myc
induced apoptosis is associated with a specific cleavage of poly(ADPribose) polymerase (PARP), suggesting that a cysteine protease of the ICE/CED-3 family is involved. Moreover, we found that the
cysteine protease CPP32
/
Caspase-3
, which is known to cleave PARP, is processed from its inactive form to an active protease composed of 17 and 12 kDa subunits; whilst Ich-1/Caspase-2 belonging to another subset of this protease family was not processed/ activated following
c-Myc
activation. The activation of CPP32 and apoptotic cell death were inhibited by addition of Z-VAD-fmk, a universal inhibitor of ICE-like proteases. Further, a selective inhibitor of CPP32-like proteases (Z-DEVD-fmk) partly inhibited apoptosis. These results provide evidence that the ICE/CED3-family proteases, CPP32 and likely others, play a critical role in the execution of a nuclear proto-oncogene,
c-Myc
-induced apoptosis.
...
PMID:Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis. 946 64
Spontaneous apoptosis was assessed in ten small-cell (SCLC) and five non-small cell (NSCLC) lung carcinoma cell lines by the TUNEL assay and chromatin cleavage. TUNEL staining showed significantly higher apoptotic index (AI) in SCLC (2-20%) compared with NSCLC lines (0.2-1%) in untreated exponentially growing cells. Six out of ten SCLC and none of the NSCLC showed DNA fragmentation when analysed by agarose gel electrophoresis. Field inversion pulse gel electrophoresis was used in a subset of cell lines and showed the presence of high molecular weight fragments in untreated SCLC lines U-1285 and U-1906 cells, but not in the NSCLC line U-1810. Important molecular determinants of apoptosis were studied by Western blot. Bcl-2 was detected at highest level in SCLC. There was no correlation between the ratio Bcl-2/Bax and AI in all tested cell lines. Neither p53 nor
c-Myc
protein status correlated to AI. Pro-
caspase-3
was expressed in all cell lines without correlation to AI and no difference between the SCLC and NSCLC groups was found. In conclusion, this study shows a high degree of spontaneous apoptosis in SCLC lines compared to NSCLC lines unrelated to Bcl-2/Bax ratio.
...
PMID:Higher spontaneous apoptotic index in small cell compared with non-small cell lung carcinoma cell lines; lack of correlation with Bcl-2/Bax. 986 2
By using flow-cytometric analysis, we examined the involvement of p53,
c-Myc
, Bcl-2 and Bax in the glutamate-induced cell death in cultured cortical neurons. The activities of caspase-1-like and
caspase-3
-like proteases were also measured after the glutamate treatment. The apoptosis rate of the cells increased after 12 h and 24 h treatment with glutamate. The temporal profile of p53,
c-Myc
, Bcl-2, Bax expression and caspases activation after glutamate treatment suggest that Bcl-2,
c-Myc
and
caspase-3
play important roles in the excitotoxic neuronal cell death. The down-regulation of Bcl-2 may be an important early stage event, which may cause the activation of
caspase-3
.
c-Myc
is also involved in the process of apoptosis though its precise role remains elusive. bFGF exhibited the capability to antagonize the neuronal apoptosis caused by glutamate. The antiapoptotic potential of bFGF may result from its attenuating effect on the down-regulation of Bcl-2 induced by glutamate and, subsequently, blockade of apoptosis cascade. This may provide a possible explanation for its neuroprotective effect against ischemic cell death.
...
PMID:Roles of p53, c-Myc, Bcl-2, Bax and caspases in glutamate-induced neuronal apoptosis and the possible neuroprotective mechanism of basic fibroblast growth factor. 1052 75
Using flow cytometric analysis, we examined the temporal changes of p53,
c-Myc
, Bcl-2, Bax expression in rat primary cortex neurons after serum deprivation. Activities of caspase-1 and
caspase-3
were also measured. Serum deprivation induced apoptosis accompanied by a rapid down-regulation of p53, Bcl-2 and an up-regulation of
c-Myc
, Bax and
caspase-3
activity. Pretreatment with basic fibroblast growth factor prevented the apoptosis with an attenuation of the changes of p53, Bcl-2, Bax levels and
caspase-3
activity but had no effect on the change of
c-Myc
level. These results suggest that serum deprivation induces apoptosis through a signaling pathway involving p53, Bcl-2, Bax,
c-Myc
and
caspase-3
. The effect of the basic fibroblast growth factor against apoptosis may result from its capability of blocking the apoptosis cascade.
...
PMID:Roles of p53, c-Myc, Bcl-2, Bax and caspases in serum deprivation-induced neuronal apoptosis: a possible neuroprotective mechanism of basic fibroblast growth factor. 1054 28
Determinants of differentiation and apoptosis in myelomonocytic leukemia cells (U937) exposed to the novel hybrid polar compound SAHA (suberoylanilide hydroxamic acid) have been examined. In contrast to hexamethylenbisacetamide (HMBA), SAHA-related maturation was limited and accompanied by marked cytoxicity. SAHA-mediated apoptosis occurred within the G0G1 and S phase populations, and was associated with decreased mitochondrial membrane potential,
caspase-3
activation, PARP degradation, hypophosphorylation/cleavage of pRB, and down-regulation of
c-Myc
, c-Myb, and B-Myb. Enforced expression of Bcl-2 or Bcl-XL inhibited SAHA-induced apoptosis, but only modestly potentiated differentiation. While SAHA induced the cyclin-dependent kinase inhibitor p21CIP1, antisense ablation of this CDKI increased, rather than decreased, SAHA-related lethality. In contrast, conditional expression of wild-type p53 failed to modify SAHA actions, but markedly potentiated HMBA-induced apoptosis. Finally, SAHA modestly increased expression/activation of the stress-activated protein kinase (SAPK/JNK); moreover, SAHA-related lethality was partially attenuated by a dominant-negative c-Jun mutant protein (TAM67). SAHA did not stimulate mitogen-activated protein kinase (MAPK), nor was lethality diminished by the specific MEK/MAPK inhibitor PD98059. These findings indicate that SAHA potently induces apoptosis in human leukemia cells via a pathway that is p53-independent but at least partially regulated by Bcl-2/Bcl-XL, p21CIP1, and the c-Jun/AP-1 signaling cascade.
...
PMID:Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53. 1059 2
This analysis attempted to ascertain whether combining the expression of
c-Myc
and
caspase-3
can improve the available prognostic information for patients with non-small cell lung carcinomas. To this purpose, the expression of
c-Myc
and
caspase-3
was determined in 128 cases of non-small cell lung carcinoma. The median survival time for patients with
c-Myc
-negative carcinomas was 89 weeks; it was only 43 weeks for patients with
c-Myc
-positive tumors (p=0.03). The estimated increased relative risk for patients with
c-Myc
-positive tumors was 1.6. The median survival time for patients with
caspase-3
-negative carcinomas was 41 weeks while patients with
caspase-3
-positive carcinomas survived for 79 weeks (p=0.06). The relative risk for patients with
caspase-3
-negative tumors was 1.5. A significant inverse relationship between the expression of
c-Myc
and
caspase-3
was observed (p=0.04). To determine whether the combination of
c-Myc
and
caspase-3
expression has a higher prognostic significance, patients were grouped based on their expressions of both variables. Patients with
c-Myc
-negative and
caspase-3
-positive tumors had the most favorable prognosis (102 weeks) while
c-Myc
-positive and
caspase-3
-negative carcinomas had the most unfavorable prognosis (22 weeks; p=0.01).
...
PMID:Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer. 1060 99
We have demonstrated that a novel Ste20-related kinase, designated SLK, mediates apoptosis and actin stress fiber dissolution through distinct domains generated by
caspase 3
cleavage. Overexpression of SLK in C2C12 myoblasts stimulated the disassembly of actin stress fibers and focal adhesions and induced apoptosis, as determined by annexin V binding and terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end labeling analysis. SLK was cleaved by
caspase 3
in vitro and in vivo during
c-Myc
-, tumor necrosis factor alpha, and UV-induced apoptosis. Furthermore, cleavage of SLK released two domains with distinct activities: an activated N-terminal kinase domain that promoted apoptosis and cytoskeletal rearrangements and a C-terminus domain that disassembled actin stress fibers. Moreover, our analysis has identified a novel conserved region (termed the AT1-46 homology domain) that efficiently promotes stress fiber disassembly. Finally, transient transfection of SLK also activated the c-Jun N-terminal kinase signaling pathway. Our results suggest that caspase-activated SLK represents a novel effector of cytoskeletal remodeling and apoptosis.
...
PMID:Caspase 3 cleavage of the Ste20-related kinase SLK releases and activates an apoptosis-inducing kinase domain and an actin-disassembling region. 1061 Dec 47
The s-Myc is similar to
c-Myc
in its ability to induce apoptosis requiring caspase activation. However, s-Myc is distinct from
c-Myc
in that it has activity to suppress tumor growth and does not require wild-type p53 to induce apoptosis. These facts suggest differential regulation between s-Myc and
c-Myc
. Here we showed that s-Myc-mediated apoptosis triggered by UV was not inhibited by the inactive form mutant JNK (APF), though
c-Myc
-mediated apoptosis was. Moreover, we found that JNK did not affect the transactivation activity of s-Myc, but stimulated that of
c-Myc
. In contrast, both Myc-mediated apoptosis and
caspase-3
-like protease activation were suppressed by kinase-negative MKK6 and an inactive form mutant p38(AGF). Our results indicate that s-Myc does not require the JNK signaling unlike
c-Myc
during UV-triggered apoptosis, but the MKK6/p38MAPK pathway might regulate common apoptotic machinery for both s-Myc and
c-Myc
upstream of caspase.
...
PMID:Differential role of the JNK and p38 MAPK pathway in c-Myc- and s-Myc-mediated apoptosis. 1062 2
1
2
3
4
5
6
7
8
9
10
Next >>